Artiva Biotherapeutics (ARTV) Share-based Compensation (2023 - 2026)
Artiva Biotherapeutics (ARTV) reported Share-based Compensation of $1.87 million for Q2 2026, up 20.4% from $1.55 million a year earlier and up 17.1% from the prior quarter.
Powered by 
Analysis
Artiva Biotherapeutics (ARTV) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Artiva Biotherapeutics' Share-based Compensation came in at $6.68 million, down 13.2% year-over-year; for FY2025, it was $6.82 million, down 2.3% from FY2024.
- By year, Share-based Compensation came in at $6.98 million in FY2024 (-1.0%) and $7.05 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation since Q1 2025.
- Year over year, Share-based Compensation gained in five of the last eight quarters, with growth averaging 12.8%.
- The high point for year-over-year Share-based Compensation in five years was Q4 2024 (growth of 56.9%); the low point was Q4 2025 (a decline of 27.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.59 million (Q1 2026), $1.59 million (Q4 2025) and $1.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Artiva Biotherapeutics | 244.36 Mn | -105.04 Mn | - | 1.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 Mn |
| Mar 31, 2026 | 1.59 Mn |
| Dec 31, 2025 | 1.59 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 1.55 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.39 Mn |
| Sep 30, 2023 | 1.37 Mn |
API Access
Artiva Biotherapeutics Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARTV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ARTV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ARTV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();